TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01271426 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT02952508 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT02729142 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02729142 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03655678 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02759419 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02555254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02854644 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02129543 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT04501523 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02745587 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02142699 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT03115567 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03065907 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03546686 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03546686 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04223479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04223479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04223479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04223479 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04223479 — Safety Biomarker (SAF): Interleukin 1
Study NCT04223479 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02237521 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00761514 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00004753 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03241511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01984385 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03560856 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00751595 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02230059 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04125550 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02835950 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04225130 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT01439282 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01439282 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00732511 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00732511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02795897 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00258336 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02152631 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01029119 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02017912 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01517048 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01517048 — Safety Biomarker (SAF): BDNF
Study NCT01430780 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04270110 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01712035 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01712035 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01479140 — Predictive Biomarker (PRD): NACAD mRNA
Genes: NACAD; KIAA0363
Study NCT02530320 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02530320 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT02530320 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT01407432 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02342808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04179136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00625170 — Safety Biomarker (SAF): DRD2
Study NCT03280563 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03280563 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03280563 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00371150 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05043324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04325438 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00549757 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01179256 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00527475 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02264509 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02603536 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03418389 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study NCT01287962 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01859832 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00713765 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04269746 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02313857 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01953393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02795520 — Predictive Biomarker (PRD): MELK mRNA
Genes: MELK; KIAA0175
Study NCT03863457 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03852290 — Safety Biomarker (SAF): MTHFR
Study NCT02534402 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT00718978 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02242604 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02770014 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02770014 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00773578 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03954405 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00129402 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04331795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04331795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00154999 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT04614363 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03457896 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03457896 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03457896 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03457896 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00855205 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02675465 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03721640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01387451 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT02499146 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01241721 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT01709149 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04613193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01245556 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04433234 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05349825 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT01528384 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT03493997 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00362362 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04191382 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00910650 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02893553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00019188 — Safety Biomarker (SAF): Interleukin 12
Study NCT04510233 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04723953 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02236806 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03272659 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT01411345 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04540705 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04064359 — Predictive Biomarker (PRD): LY75 mRNA
Genes: LY75; CD205; CLEC13B
Study NCT04541433 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04530214 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT00979420 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01956903 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00954694 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02005913 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03009032 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03009032 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00540904 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04555551 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT02012985 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT01368107 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00319774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04694495 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02524925 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT01984489 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03412175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04355429 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02743390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02743390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02743390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02743390 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT02832973 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02832973 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02072668 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00284947 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00473343 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02755311 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT02092584 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT00822679 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00822679 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04294498 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00295555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01767090 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01071304 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00687193 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04476342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04476342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04476342 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04476342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00495196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03187288 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT01275651 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01721915 — Predictive Biomarker (PRD): DHCR7 mRNA
Genes: DHCR7; D7SR
Study NCT01721915 — Predictive Biomarker (PRD): CYP2R1 mRNA
Genes: CYP2R1
Study NCT01721915 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01721915 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT04638543 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02032823 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00324259 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03000907 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03000907 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01508702 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04714333 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02183701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02564640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02971748 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02971748 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02971748 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04511247 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01463085 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04158362 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02094573 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00271817 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00271817 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03767023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02760030 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03750916 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00973531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03673345 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03897777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05513430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02631460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02631460 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04058106 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04375202 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02613962 — Predictive Biomarker (PRD): CLIP2 mRNA
Genes: CLIP2; CYLN2; KIAA0291; WBSCR3; WBSCR4; WSCR4
Study NCT01115556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01293513 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03794102 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00667134 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00718783 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT01424514 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT01102972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT00436696 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT04669951 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT00136435 — Surrogate Endpoint (SUR): Serum asparaginase
Study NCT01806441 — Predictive Biomarker (PRD): NPC1L1 mRNA
Genes: NPC1L1
Study NCT01806441 — Predictive Biomarker (PRD): ABCG5 mRNA
Genes: ABCG5
Study NCT01806441 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT01806441 — Predictive Biomarker (PRD): SLC27A4 mRNA
Genes: SLC27A4; ACSVL4; FATP4
Study NCT04506229 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03112096 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03706755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02335073 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01322035 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00836693 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02796859 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02796859 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01704716 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT02893176 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02893176 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT02893176 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT02893176 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT02893176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study NCT00471939 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00718484 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02833974 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT00820183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01491737 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01491737 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05359341 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01273584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01220128 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02040324 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03860649 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03860649 — Safety Biomarker (SAF): BDNF
Study NCT01751555 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01467674 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT00819780 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00853307 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT00643747 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT00075023 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02656095 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT04117958 — Predictive Biomarker (PRD): MUC17 mRNA
Genes: MUC17; MUC3
Study NCT04837274 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02443363 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01954498 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01633008 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00459316 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT03324269 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03924050 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04216277 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04216277 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04308382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01266785 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01266785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01909752 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02638194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02638194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02638194 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00637208 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01206062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02500680 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT00670319 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03114176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02032446 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04420637 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS